Stocks to Watch
Stocks to Watch is Investing Daily’s number one daily offering for investors looking to gain the maximum edge for their portfolio. Full of unique, fresh market insights, Stocks to Watch delivers actionable guidance on the most profitable investment opportunities from today’s headlines.
Check out the Stocks to Watch archive below for in-depth tips and strategies on investing profitably in today’s market. You will uncover how legislation is affecting the economy, where the highest yields are hiding, where strong fundamentals are being overlooked, and much more.
If you’re looking for the latest ideas to invigorate your portfolio, Stocks to Watch is the best place to start.
One of Starpharma's directors has filed that he added another 6 percent to his directly held position in the company in the last month.
In a couple recent announcements in March, Starpharma CEO/Managing Director Jackie Fairley has added 20,000 more shares to her initial position in common stock.
It just came over the wire that the Data Safety Monitoring Board (DSMB) has once again recommended that the two pivotal Phase III clinical trials for pSivida’s Medidur ocular drug delivery system can continue under the current protocol without change.
Spire Corp will be hosting its fourth quarter and full-year 2007 results at the end of this month.
In this issue, I’m covering the outlook for three major food markets--corn, soybeans and wheat--and I’ll answer the following question: Should food futures be a component of your investment portfolio?
Little diversified solar panel/medical device/semi chip maker Spire Corp announced earlier this week that it received another turnkey solar panel production line from its Spanish client Fluitecnik SA.
One of my favorite Pioneers reported a wider loss for full-year 2007, hurt by warranty replacement costs and higher research and development expenses, despite higher revenues.
Two other newsworthy items have come across the wires on Motorola today.
Several Portfolio companies have announced news worth repeating. Here's a quick update on where these plays stand.
News just came across the wire that Altairnano CEO Alan Gotcher has resigned. I have a call into his office and the company’s PR chief to get more information.